Replies to post #5513 on Cellectar Biosciences Inc (CLRB)

[Crusader]

Last trade today looks to be $1.50

or lower. News of Biotech conference and the latest patents are not going to establish a new base and a new uptrend.

It will take Clinical trial success and corresponding income growth potential to get us to $3 and $7 again.

It is all about earnings and verified potential earning. Share price follows those factors as we all know.

GOOD luck to all longs!